HOME > TOP STORIES

TOP STORIES

ORGANIZATION Japan Self-Medication Industry Requests Health Minister to Remove JMA, JPA Members from OTC Drug Review Council

October 9, 2013
ORGANIZATION Blanket 14-Day Prescription Limit Should Be Scrapped: EFPIA Japan Chair

October 8, 2013
BUSINESS Quintiles Aims to Expand Business in Japan with More Employees: CEO

October 8, 2013
BUSINESS 3 Combination Drugs for Asthma, COPD Get Approval to Fuel Competition; NHI Price Listing Expected in November

October 7, 2013
ORGANIZATION Diovan Issue　is “Isolated Example,” Confidence in Japan Clinical Trials Not Lost: President Viehbacher of EFPIA

October 7, 2013
REGULATORY NIBIO to Strengthen Academia’s Drug Discovery Support Initiatives in Order to Evaluate 400 Research Themes by FY2015

October 4, 2013
ORGANIZATION JPMA Compliance Committee to Decide Penalties for Novartis for Diovan Case as Requested by Dr Teshirogi

October 3, 2013
BUSINESS Another Administrative Action Taken Against MTPC on Medway Injection; 3rd in 4 Years

October 2, 2013
REGULATORY Interim Report of Diovan Panel Fails to Lay Bare Who Altered Data, for What Purpose

October 1, 2013
BUSINESS Amgen Astellas BioPharma to Go on Stream Oct. 1; JV Chief Takahashi Eager to Make It a “Category Leader”

September 30, 2013
REGULATORY Japan Health Minister Meets Exec of Swiss Novartis, Seeks Cooperation in Diovan Probe

September 27, 2013
REGULATORY JPWA Seeks Generic Name Listing for Wider Range of Generics

September 27, 2013
BUSINESS 3 Pharma Groups Demand Permanent Introduction of Premium at CSIMC; Healthcare Rep Still Wary

September 26, 2013
BUSINESS Daiichi Sankyo Dogged by Renewed Quality Woes at Ranbaxy; FDA Mute on Details

September 26, 2013
ACADEMIA National University Hospital Council Urges Immediate Check-Up on Hospital’s Clinical Research Systems

September 25, 2013
BUSINESS Unique Marketing System Jacks Up Profits at Vital KSK; Customer-by-Customer Cost Analyses Lend Support

September 24, 2013
REGULATORY FTC’s Legal Intervention in Diovan Issue Possible, but Only with New Facts: Lawyer

September 20, 2013
BUSINESS MTPC Completes Acquisition of Medicago, Now Ready to Bolster Vaccine Development

September 20, 2013
BUSINESS Daiichi Sankyo, Mitsubishi UFJ Capital Establish New Fund to Support Ventures in Japan

September 19, 2013
BUSINESS Demand Growing for Transdermal Patches in Graying Japan, Drug Makers Gear Up for Development

September 18, 2013

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Pharma Renews Call to Scrap “Spillover,” “Huge-Seller” Rules as FY2026 Talks Enter Final Stretch

By Ken Yoshino

Japan’s drug pricing panel held its final round of industry hearings on December 10 as it heads toward the FY2026…

COMMENTARY

FY2026 Reform Debate for Drug Pricing Nears the Finish Line, Balance Needed

By Takashi Ebisawa

Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…